| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 184 |
| 1 | AZATHIOPRINE | 155 |
| 2 | PREDNISONE | 90 |
| 3 | METHOTREXATE SODIUM | 89 |
| 4 | ADALIMUMAB | 76 |
| 5 | METHOTREXATE | 74 |
| 6 | MERCAPTOPURINE | 71 |
| 7 | ETOPOSIDE | 64 |
| 8 | TACROLIMUS | 59 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN GROWTH HORMONE | 2 | 0.0286 |
| 1 | PRALATREXATE | 7 | 0.0108 |
| 2 | AURANOFIN | 1 | 0.0049 |
| 3 | AZATHIOPRINE SODIUM | 12 | 0.0047 |
| 4 | NELARABINE | 4 | 0.0041 |
| 5 | MERCAPTOPURINE | 71 | 0.0041 |
| 6 | ANAKINRA | 48 | 0.0028 |
| 7 | ACETAZOLAMIDE SODIUM | 15 | 0.0024 |
| 8 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| 9 | PENTOSTATIN | 2 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 213 |
| 1 | Purine Antimetabolite [EPC] | 155 |
| 2 | Corticosteroid [EPC] | 140 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 74 |
| 4 | Topoisomerase Inhibitor [EPC] | 64 |
| 5 | Alkylating Drug [EPC] | 50 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 48 |
| 7 | Aminosalicylate [EPC] | 37 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 21 |
| 9 | Calcium [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 48 | 0.0028 |
| 1 | Purine Antimetabolite [EPC] | 155 | 0.0016 |
| 2 | Topoisomerase Inhibitor [EPC] | 64 | 0.0008 |
| 3 | Carbonic Anhydrase Inhibitor [EPC] | 15 | 0.0007 |
| 4 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 5 | Aminosalicylate [EPC] | 37 | 0.0004 |
| 6 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Photoenhancer [EPC] | 1 | 0.0003 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 213 | 0.0002 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |